The University of Tennessee, Knoxville

utk.edu

Total trials

92

Active

23

Phase 3

0

Total enrollment

12,074

Read this sponsor's pipeline like an analyst.

Generate a written report: strategic focus, priority programs, pipeline shape, recent terminations and momentum, and the trials worth watching in the next 12 months.

~15-30 sec · cached for 24h

Pipeline matrix

Showing 0 of 0 active programs · click any cell for trials

InterventionEarly Phase 1Phase 1Phase 2Phase 3Phase 4N/ATotal

Next readouts

No upcoming readouts found.

Top conditions

  • Obesity17
  • Total Knee Arthroplasty7
  • Overweight6
  • Knee Prosthesis4
  • Physical Activity4
  • Osteoarthritis, Knee4
  • Childhood Obesity4
  • Breast Cancer4

Frequently asked questions about The University of Tennessee, Knoxville

How many clinical trials does The University of Tennessee, Knoxville have on ClinicalTrials.gov?
The University of Tennessee, Knoxville is listed as the lead sponsor on 92 clinical trials in ClinicalTrials.gov, 23 of which are currently active (recruiting, enrolling, or ongoing).
How many of The University of Tennessee, Knoxville's trials are in Phase 3?
0 of The University of Tennessee, Knoxville's trials are in Phase 3.
What therapeutic areas does The University of Tennessee, Knoxville focus on?
The University of Tennessee, Knoxville's most-studied conditions on ClinicalTrials.gov are Obesity, Total Knee Arthroplasty, Overweight, Knee Prosthesis, Physical Activity.